INS and cystic fibrosis: Based on an initiative of the German CF-Foundation (Mukoviszidose e.V.), the present study tries to answer the question, whether oral therapy with repaglinide is as effective as insulin therapy in CF patients with early diagnosed diabetes mellitus.